Skip to main content
. 2020 Nov 5;10(11):e039636. doi: 10.1136/bmjopen-2020-039636

Table 1.

Overview of outcomes and planned comparisons

Outcome Comparisons
CIN2+ Intervention vs reference group
CIN3+ Intervention vs reference group
Screening participation Intervention group: self-sampling vs GP-sampling
Screening history Intervention group: self-sampling vs GP-sampling
HPV positivity rate Intervention group: self-sampling vs GP-sampling
HPV type distribution Intervention group: self-sampling vs GP-sampling
Cytology results* Intervention group
Compliance to follow-up among HPV positive self-samplers Intervention group
Proportion and results of cervical cytology samples Reference group
Colposcopies and conizations Intervention vs reference group
Cervical cancer incidence Intervention vs reference group

*Only available for women with an HPV positive GP-sample or GP-triage sample following an HPV positive self-sample.

CIN2+, CIN2, CIN3/AIS and cancer; CIN3+, CIN3/AIS and cancer; GP, general practitioner; HPV, human papillomavirus.